Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
批准号:
10213951
负责人:
Stephen Paul Diggle
金额:
$50.81万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-20 至 2021-04-08
关键词:
AcuteAffectAgeAntibiotic ResistanceAntibiotic TherapyAntibiotic susceptibilityAntibioticsAntimicrobial ResistanceAntimicrobial susceptibilityAreaBacteriaBacterial GenomeBiological AssayChronicClinicClinicalCommunicable DiseasesCommunitiesConfocal MicroscopyCorrelation StudiesCystic FibrosisDevelopmentDiagnosticDiagnostic testsEvolutionFutureGenesGeneticGenetic DiseasesGenetic HeterogeneityGenetic RecombinationGoalsGrowthHeterogeneityIndividualLeadLifeLinkLungLung diseasesLung infectionsMethodologyMicrobial BiofilmsModelingMucinsMutationOrganismOutcomePatientsPhenotypePhysiologyPopulationPopulation DynamicsPopulation HeterogeneityPredispositionPrivatizationProductionPseudomonas aeruginosaPseudomonas aeruginosa infectionPulmonary FibrosisRegulatory PathwayResearchResistanceRespiratory physiologySamplingSocial InteractionSourceSputumStructureTestingTimeVariantVirulenceVirulence FactorsWorkbasebeta-Lactamasecomputational platformcystic fibrosis infectioncystic fibrosis patientsde novo mutationemerging antimicrobial resistanceexperienceexperimental studyfitnessfollow-upgenome analysisgenome wide association studygenomic biomarkergenomic locusgenomic signaturehomologous recombinationin vivoinsightmRNA Differential Displaysnovelpathogenpathogenic bacteriapredict clinical outcomereconstructionresistance mechanismresistant strainsocialtraittranscriptome sequencingtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Cystic fibrosis (CF) is a genetic disease that results in persistent and chronic lung infections
which reduce lung function over time. Pseudomonas aeruginosa (Pa), an opportunistic bacterial
pathogen that infects patients lungs at a young age and persists throughout life, is a major
contributing factor. Aggressive antibiotic regimes have significantly prolonged the lives of CF
patients, yet Pa populations still dominate during end stage lung disease. Why antibiotic
treatments against Pa ultimately fail remains unclear, but one plausible explanation is that Pa
populations in the CF lung gain higher levels of AMR collectively as they become more
phenotypically and genetically diverse over time. Understanding how Pa population
heterogeneity contributes to antimicrobial resistance (AMR), and how Pa population diversity
contributes to the organism’s survival, are important considerations for the future development
of effective diagnostic and treatment strategies. Understanding of in vivo AMR is limited by a
lack of empirical studies focused on how factors such as evolutionary trade-offs and social
interactions between Pa isolates affect heterogeneity and influence AMR. This study will focus
on the impact of intra-species diversity on AMR using a unique set of Pa strain populations
already collected from 50 sputum samples. The main goals are to (i) reveal how the level of
heterogeneity in Pa populations in CF patients determines the extent of AMR; (ii) ascertain
evolutionary factors that leads to AMR heterogeneity; (iii) identify in vivo genomic signatures of
AMR using Genome Wide Association Studies (GWAS). The research described in this project
will provide valuable insights into antimicrobial resistance in chronic CF infection, because it will
introduce novel methodology for antimicrobial susceptibility testing in clinics by taking population
dynamics into account. Outcomes could also lead to new models and platforms for studying the
evolution of virulence and AMR in populations. In the future, the ideas presented here can be
further expanded to include studies on other species important in CF and other polymicrobial
communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
-
批准号:10206986
-
项目类别:
-
资助金额:$33.17万
-
财政年份:2021
-
负责人:Stephen Paul Diggle
-
依托单位:
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
-
批准号:10590655
-
项目类别:
-
资助金额:$48.06万
-
财政年份:2021
-
负责人:Stephen Paul Diggle
-
依托单位:
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
-
批准号:10390346
-
项目类别:
-
资助金额:$48.06万
-
财政年份:2021
-
负责人:Stephen Paul Diggle
-
依托单位:
海外基金